Solid Biosciences (SLDB) Current Leases (2018 - 2026)

Solid Biosciences has disclosed Current Leases across 9 years of filings, most recently posting $2.2 million for Q1 2026.

• Current Leases for Q1 2026 came in at $2.2 million, up 99.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 99.64% YoY), and the FY2025 annual result was $2.1 million, up 17.68% from the prior year.
• Current Leases came in at $2.2 million for Q1 2026 at Solid Biosciences, up from $2.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.2 million in Q1 2026 to a low of $353000.0 in Q3 2022.
• The 5-year median for Current Leases is $1.8 million (2024), against an average of $1.5 million.
• Across the five-year window, Current Leases surged 423.23% in 2023 and sank 73.38% in 2024, its largest moves.
• Solid Biosciences' Current Leases stood at $668000.0 in 2022, then jumped by 177.69% to $1.9 million in 2023, then dropped by 3.67% to $1.8 million in 2024, then increased by 17.68% to $2.1 million in 2025, then climbed by 4.04% to $2.2 million in 2026.
• The last three Current Leases figures came in at $2.2 million (Q1 2026), $2.1 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.